Skip to main content

Year: 2022

The Real Good Food Company Announces Director Resignation

CHERRY HILL, N.J., Dec. 22, 2022 (GLOBE NEWSWIRE) — The Real Good Food Company Inc. (Nasdaq: RGF) (the “Company”), today announced that Deanna T. Brady has resigned as a Director of the Company, effective immediately. The resignation was at Ms. Brady’s direction given the recent evolution of Real Good Food’s product portfolio into products that are similar to those of her employer, Hormel Foods. Bryan Freeman, Executive Chairman of The Real Good Food Company, said: “On behalf of the Board of Directors and executive management team, I wish to extend our gratitude to Deanna and thank her for her valuable contributions over the last year. She has been an extraordinary leader and we wish her all the best in her future endeavors. “We are working towards identifying a replacement to fill Ms. Brady’s former roles as Chair of the Nominating...

Continue reading

Osisko Appoints Vice President Capital Markets

MONTRÉAL, Dec. 22, 2022 (GLOBE NEWSWIRE) — Osisko Gold Royalties Ltd (the “Corporation” or “Osisko”) (OR: TSX & NYSE) is pleased to announce the appointment of Grant Moenting, P.Eng., as Vice President, Capital Markets, beginning in January. Grant brings to the Corporation 16 years of experience and in-depth knowledge of the mining business. For the past eight years, Grant was a mining sales specialist on the institutional equity sales desk at Scotiabank Global Banking and Markets. Grant was ranked as a Brendan Woods TopGun Sales Professional (as voted by institutional clients) for the past four years, in addition to being ranked #1 by Greenwich Associates for Best Sales Coverage for Metals & Mining over the same period. Prior to this, he gained experience across multiple roles in mining equity research and corporate...

Continue reading

California Water Service Sees Seventh Straight Month of Water Savings

SAN JOSE, Calif., Dec. 22, 2022 (GLOBE NEWSWIRE) — Although the weather has started to cool, California Water Service (Cal Water) customers continued to reduce their water use for the seventh month in a row in November. More than half of Cal Water’s districts surpassed 15% in reductions; company-wide, Cal Water reduced water use by 13.6% compared to November 2020. “I would like to thank our customers for all of their hard work stepping up conservation efforts this year,” said Martin A. Kropelnicki, President and CEO. “While we are hoping for a wet winter, we urge our customers to stay mindful of their water use and continue to save water every day.” During these wetter months, as more water is used inside homes and businesses, Cal Water encourages customers to remember simple indoor water-saving tips, such as turning off the tap...

Continue reading

Stifel Reports November 2022 Operating Data

ST. LOUIS, Dec. 22, 2022 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today reported selected operating results for November 30, 2022 in an effort to provide timely information to investors on certain key performance metrics. Due to the limited nature of this data, a consistent correlation to earnings should not be assumed. Ronald J. Kruszewski, Chairman and Chief Executive Officer, said, “Our Wealth Management business continued its strong performance in November. Client cash balances increased 2.1% and continued to increase month-to-date in December, driven by net inflows. Additionally, improved equity market performance and solid recruiting of financial advisors resulted in growth in total client assets and fee-based client assets of 4.5% and 4.7%, respectively. Our Institutional Group is on track for a strong year despite...

Continue reading

Nyxoah Files Shelf Registration Statement and Announces At-the-Market Equity Offering Program

INSIDE INFORMATIONREGULATED INFORMATION Nyxoah Files Shelf Registration Statement and Announces At-the-Market Equity Offering Program Mont-Saint-Guibert, Belgium – December 22, 2022, 10:10pm CET / 4:10pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that it has filed a $200 million shelf registration statement on Form F-3 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (the “SEC”).  Once declared effective by the SEC, the Registration Statement would permit the Company to sell, from time to time, up to $200 million in aggregate value of its common stock, preferred stock, debt securities, warrants, and/or units. The Registration...

Continue reading

Mersana Therapeutics Announces Research Collaboration and Commercial License Agreement with Merck KGaA, Darmstadt, Germany to Develop Novel Immunosynthen Antibody-Drug Conjugates

Collaboration focuses on discovering novel STING-agonist ADCs for up to two targets leveraging Mersana’s proprietary immunostimulatory platform Mersana to receive $30 million upfront payment, up to $800 million in development, regulatory and commercial milestones, and tiered royalties up to the low double-digit percentages on net sales Mersana’s third significant collaboration agreement in 2022 reflects its increasing role as an ADC partner of choiceCAMBRIDGE, Mass., Dec. 22, 2022 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced a research collaboration and commercial license agreement with a subsidiary of Merck KGaA,...

Continue reading

Mission Produce™ Announces Fiscal 2022 Fourth Quarter Financial Results

OXNARD, Calif., Dec. 22, 2022 (GLOBE NEWSWIRE) — Mission Produce, Inc. (Nasdaq: AVO) (“Mission” or the “Company”), a world leader in sourcing, producing, and distributing fresh Hass avocados with additional offerings in mangos and blueberries, today reported its financial results for the fiscal fourth quarter ended October 31, 2022. Fiscal Fourth Quarter 2022 Highlights:Total revenue of $238.0 million was flat with the prior year period, including the Blueberries segment consolidation which was not comparable to the prior year period. Average avocado selling price decreased by 10%, partially offset by a 6% increase in avocado volume sold, compared to the same period last year Net loss of $(42.0) million, or $(0.59) per diluted share, which includes a non-cash charge of $49.5 million related to goodwill impairment; compared to...

Continue reading

Update on Proposed Acquisition of Grupo Somar

MIAMI and BARRANQUILLA, Colo., Dec. 22, 2022 (GLOBE NEWSWIRE) — Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announces an update on its previously reported definitive agreement, dated as of May 16, 2022 (the “SPA”), to acquire Grupo Somar (including Grupo Farmacéutico Somar, S.A.P.I de C.V., Química y Farmacia S.A. de C.V., Gelcaps Exportadora de Mexico S.A. de C.V. and related entities) from the sellers under the SPA (the “Sellers”). As previously reported, the Company initially expected that the closing (the “Closing”) of the acquisition of Grupo Somar by the Company (the “Acquisition”) would occur on October 14, 2022; however, on October 13, 2022, the Company was informed by the Sellers that a condition to the Closing would purportedly...

Continue reading

AF Acquisition Corp. Amends Charter and Announces Decision to Liquidate

Palm Beach, FL, Dec. 22, 2022 (GLOBE NEWSWIRE) — On December 19, 2022, the stockholders of AF Acquisition Corp. (the “Company”) approved (i) an amendment to the Company’s amended and restated certificate of incorporation (the “Charter”) to extend the date by which the Company would be required to consummate a business combination from March 23, 2023 to August 23, 2023 (the “Extension Amendment”), (ii) an amendment to the Charter to permit the Company’s Board, in its sole discretion, to elect to wind up the Company’s operations on an earlier date (the “Liquidation Amendment” and, together with the Extension Amendment, the “Charter Amendments”), (iii) an amendment to the Company’s investment management trust agreement, dated as of March 18, 2021, by and between the Company and Continental Stock Transfer & Trust Company, to extend...

Continue reading

European Energy A/S: Agreement signed for the sale of a solar park in Denmark with a total capacity of 55 MW

Company announcement 16/2022 (22.12.2022) Today, European Energy signed an agreement for the sale of a solar park in Denmark with a total capacity of 55 MW. The solar park was grid-connected in January 2022 and produces green electricity to cover the consumption of 15,000 households. Closing is expected to take place this year. The sale will contribute positively to European Energy’s financial position. European Energy’s financial guidance for 2022 remains unchanged at an EBITDA of EUR 135m and profit before tax of EUR 100m. For further information, please contact Investor Relations: investor.relations@europeanenergy.com. This announcement has been made in accordance with the market abuse regulation (regulation (EU) no. 596/2014 on market abuse).

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.